Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.

Virostko J, Capasso A, Yankeelov TE, Goodgame B.

Cancer. 2019 Nov 1;125(21):3828-3835. doi: 10.1002/cncr.32347. Epub 2019 Jul 22.

PMID:
31328273
2.

Translating preclinical MRI methods to clinical oncology.

Hormuth DA 2nd, Sorace AG, Virostko J, Abramson RG, Bhujwalla ZM, Enriquez-Navas P, Gillies R, Hazle JD, Mason RP, Quarles CC, Weis JA, Whisenant JG, Xu J, Yankeelov TE.

J Magn Reson Imaging. 2019 Nov;50(5):1377-1392. doi: 10.1002/jmri.26731. Epub 2019 Mar 29. Review.

PMID:
30925001
3.

Magnetization Transfer MRI of Breast Cancer in the Community Setting: Reproducibility and Preliminary Results in Neoadjuvant Therapy.

Virostko J, Sorace AG, Wu C, Ekrut D, Jarrett AM, Upadhyaya RM, Avery S, Patt D, Goodgame B, Yankeelov TE.

Tomography. 2019 Mar;5(1):44-52. doi: 10.18383/j.tom.2018.00019.

4.

Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset.

Virostko J, Williams J, Hilmes M, Bowman C, Wright JJ, Du L, Kang H, Russell WE, Powers AC, Moore DJ.

Diabetes Care. 2019 Feb;42(2):248-257. doi: 10.2337/dc18-1507. Epub 2018 Dec 14.

PMID:
30552135
5.

Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis.

Saunders DC, Brissova M, Phillips N, Shrestha S, Walker JT, Aramandla R, Poffenberger G, Flaherty DK, Weller KP, Pelletier J, Cooper T, Goff MT, Virostko J, Shostak A, Dean ED, Greiner DL, Shultz LD, Prasad N, Levy SE, Carnahan RH, Dai C, Sévigny J, Powers AC.

Cell Metab. 2019 Mar 5;29(3):745-754.e4. doi: 10.1016/j.cmet.2018.10.007. Epub 2018 Nov 15.

PMID:
30449685
6.

Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation.

Bobo MF, Bao S, Huo Y, Yao Y, Virostko J, Plassard AJ, Lyu I, Assad A, Abramson RG, Hilmes MA, Landman BA.

Proc SPIE Int Soc Opt Eng. 2018 Mar;10574. pii: 105742V. doi: 10.1117/12.2293751.

7.

Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.

Sorace AG, Wu C, Barnes SL, Jarrett AM, Avery S, Patt D, Goodgame B, Luci JJ, Kang H, Abramson RG, Yankeelov TE, Virostko J.

J Magn Reson Imaging. 2018 Mar 23. doi: 10.1002/jmri.26011. [Epub ahead of print]

8.

Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions.

Cassat JE, Moore JL, Wilson KJ, Stark Z, Prentice BM, Van de Plas R, Perry WJ, Zhang Y, Virostko J, Colvin DC, Rose KL, Judd AM, Reyzer ML, Spraggins JM, Grunenwald CM, Gore JC, Caprioli RM, Skaar EP.

Sci Transl Med. 2018 Mar 14;10(432). pii: eaan6361. doi: 10.1126/scitranslmed.aan6361.

9.

Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Sorace AG, Partridge SC, Li X, Virostko J, Barnes SL, Hippe DS, Huang W, Yankeelov TE.

J Med Imaging (Bellingham). 2018 Jan;5(1):011019. doi: 10.1117/1.JMI.5.1.011019. Epub 2018 Jan 22.

10.

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.

Virostko J, Hainline A, Kang H, Arlinghaus LR, Abramson RG, Barnes SL, Blume JD, Avery S, Patt D, Goodgame B, Yankeelov TE, Sorace AG.

J Med Imaging (Bellingham). 2018 Jan;5(1):011011. doi: 10.1117/1.JMI.5.1.011011. Epub 2017 Nov 24.

11.

Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.

Virostko J, Hilmes M, Eitel K, Moore DJ, Powers AC.

PLoS One. 2016 Jul 8;11(7):e0158825. doi: 10.1371/journal.pone.0158825. eCollection 2016.

13.

A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurity.

Dou S, Virostko J, Greiner DL, Powers AC, Liu G.

Nucleosides Nucleotides Nucleic Acids. 2015;34(2):69-78. doi: 10.1080/15257770.2014.958236.

14.

Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.

Felix DD, Gore JC, Yankeelov TE, Peterson TE, Barnes S, Whisenant J, Weis J, Shoukouhi S, Virostko J, Nickels M, McIntyre JO, Sanders M, Abramson V, Tantawy MN.

Nucl Med Biol. 2015 Mar;42(3):269-73. doi: 10.1016/j.nucmedbio.2014.11.010. Epub 2014 Dec 6.

15.

Reply to "Assessment of MRI issues at 7 T".

Dula AN, Virostko J, Shellock FG.

AJR Am J Roentgenol. 2014 Nov;203(5):W561. doi: 10.2214/AJR.14.13033. No abstract available.

PMID:
25341180
16.

Non-invasive bioluminescence imaging of β-cell function in obese-hyperglycemic [ob/ob] mice.

Patel M, Gleason A, O'Malley S, Connolly B, Suresch D, Virostko J, Phillips N, Lin SA, Chen TB, Klimas M, Hargreaves RJ, Sur C, Williams DL Jr, Powers AC, Bednar B.

PLoS One. 2014 Sep 8;9(9):e106693. doi: 10.1371/journal.pone.0106693. eCollection 2014.

17.

Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice.

Dou S, Virostko J, Rusckowski M, Greiner DL, Powers AC, Liu G.

Front Pharmacol. 2014 Jul 24;5:172. doi: 10.3389/fphar.2014.00172. eCollection 2014.

18.

Assessment of MRI issues at 7 T for 28 implants and other objects.

Dula AN, Virostko J, Shellock FG.

AJR Am J Roentgenol. 2014 Feb;202(2):401-5. doi: 10.2214/AJR.13.10777.

PMID:
24450683
19.

SPARCL1 suppresses metastasis in prostate cancer.

Xiang Y, Qiu Q, Jiang M, Jin R, Lehmann BD, Strand DW, Jovanovic B, DeGraff DJ, Zheng Y, Yousif DA, Simmons CQ, Case TC, Yi J, Cates JM, Virostko J, He X, Jin X, Hayward SW, Matusik RJ, George AL Jr, Yi Y.

Mol Oncol. 2013 Dec;7(6):1019-30. doi: 10.1016/j.molonc.2013.07.008. Epub 2013 Jul 20.

20.

A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.

Xie J, Wang C, Virostko J, Manning HC, Pham W, Bauer J, Gore JC.

Chembiochem. 2013 Aug 19;14(12):1494-503. doi: 10.1002/cbic.201300142. Epub 2013 Jul 24.

21.

Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model.

Virostko J, Radhika A, Poffenberger G, Dula AN, Moore DJ, Powers AC.

PLoS One. 2013;8(3):e57784. doi: 10.1371/journal.pone.0057784. Epub 2013 Mar 6.

22.

Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands.

Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20719-24. doi: 10.1073/pnas.1109480108. Epub 2011 Dec 5.

23.

Magnetic nanoparticles for imaging dendritic cells.

Kobukai S, Baheza R, Cobb JG, Virostko J, Xie J, Gillman A, Koktysh D, Kerns D, Does M, Gore JC, Pham W.

Magn Reson Med. 2010 May;63(5):1383-90. doi: 10.1002/mrm.22313.

24.

Validation of bioluminescent imaging techniques.

Virostko J, Jansen ED.

Methods Mol Biol. 2009;574:15-23. doi: 10.1007/978-1-60327-321-3_2.

PMID:
19685296
25.

Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation.

Virostko J, Radhika A, Poffenberger G, Chen Z, Brissova M, Gilchrist J, Coleman B, Gannon M, Jansen ED, Powers AC.

Mol Imaging Biol. 2010 Jan-Feb;12(1):42-53. doi: 10.1007/s11307-009-0240-1. Epub 2009 Jun 23.

26.

A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals.

Virostko J, Xie J, Hallahan DE, Arteaga CL, Gore JC, Manning HC.

Mol Imaging Biol. 2009 May-Jun;11(3):204-12. doi: 10.1007/s11307-008-0193-9. Epub 2009 Jan 7.

27.

Molecular imaging of the pancreas in small animal models.

Virostko J, Powers AC.

Gastroenterology. 2009 Feb;136(2):407-9. doi: 10.1053/j.gastro.2008.12.024. Epub 2008 Dec 25. Review. No abstract available.

28.

Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.

Manning HC, Merchant NB, Foutch AC, Virostko JM, Wyatt SK, Shah C, McKinley ET, Xie J, Mutic NJ, Washington MK, LaFleur B, Tantawy MN, Peterson TE, Ansari MS, Baldwin RM, Rothenberg ML, Bornhop DJ, Gore JC, Coffey RJ.

Clin Cancer Res. 2008 Nov 15;14(22):7413-22. doi: 10.1158/1078-0432.CCR-08-0239.

29.

Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images.

Virostko J, Powers AC, Jansen ED.

Appl Opt. 2007 May 1;46(13):2540-7.

PMID:
17429468
30.

Effect of optical tissue clearing on spatial resolution and sensitivity of bioluminescence imaging.

Jansen ED, Pickett PM, Mackanos MA, Virostko J.

J Biomed Opt. 2006 Jul-Aug;11(4):041119.

31.

Current status of imaging pancreatic islets.

Virostko J, Jansen ED, Powers AC.

Curr Diab Rep. 2006 Aug;6(4):328-32.

PMID:
16879787
32.

Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging.

Fowler M, Virostko J, Chen Z, Poffenberger G, Radhika A, Brissova M, Shiota M, Nicholson WE, Shi Y, Hirshberg B, Harlan DM, Jansen ED, Powers AC.

Transplantation. 2005 Apr 15;79(7):768-76.

PMID:
15818318
33.

Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants.

Virostko J, Chen Z, Fowler M, Poffenberger G, Powers AC, Jansen ED.

Mol Imaging. 2004 Oct;3(4):333-42.

PMID:
15802050

Supplemental Content

Loading ...
Support Center